These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31112621)

  • 41. Effect of size and disease on estimated deposition of drugs administered using jet nebulization in children with cystic fibrosis.
    Coates AL; Allen PD; MacNeish CF; Ho SL; Lands LC
    Chest; 2001 Apr; 119(4):1123-30. PubMed ID: 11296179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
    Ratjen F; Munck A; Kho P; Angyalosi G;
    Thorax; 2010 Apr; 65(4):286-91. PubMed ID: 19996339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?
    Miller JL; Lepa TM; Ranallo C; Chaaban H; Skrepnek GH; Johnson PN
    Pediatr Crit Care Med; 2017 Dec; 18(12):e615-e620. PubMed ID: 29206744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
    Hamed K; Debonnett L
    Ther Adv Respir Dis; 2017 May; 11(5):193-209. PubMed ID: 28470103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?
    Bos AC; Mouton JW; van Westreenen M; Andrinopoulou ER; Janssens HM; Tiddens HAWM
    J Antimicrob Chemother; 2017 Dec; 72(12):3435-3442. PubMed ID: 29029057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG; Gembitskaia TE
    Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of breathing mode on tobramycin serum levels using the I-neb AAD system in adults with cystic fibrosis.
    van Velzen AJ; Uges JW; Le Brun PP; Shahbabai P; Touw DJ; Heijerman HG
    J Cyst Fibros; 2015 Nov; 14(6):748-54. PubMed ID: 25636858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S; Plant ND; Spencer DA
    J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis.
    Downes KJ; Dong M; Fukuda T; Clancy JP; Haffner C; Bennett MR; Vinks AA; Goldstein SL
    J Antimicrob Chemother; 2017 Jan; 72(1):254-260. PubMed ID: 27585963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols.
    Coates AL; MacNeish CF; Meisner D; Kelemen S; Thibert R; MacDonald J; Vadas E
    Chest; 1997 May; 111(5):1206-12. PubMed ID: 9149571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.
    Sawicki GS; Chou W; Raimundo K; Trzaskoma B; Konstan MW
    J Cyst Fibros; 2015 Nov; 14(6):777-83. PubMed ID: 25921451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The choice of compressor effects the aerosol parameters and the delivery of tobramycin from a single model nebulizer.
    Standaert TA; Vandevanter D; Ramsey BW; Vasiljev M; Nardella P; Gmur D; Bredl C; Murphy A; Montgomery AB
    J Aerosol Med; 2000; 13(2):147-53. PubMed ID: 11010595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary Drug Delivery Following Continuous Vibrating Mesh Nebulization and Inspiratory Synchronized Vibrating Mesh Nebulization During Noninvasive Ventilation in Healthy Volunteers.
    Michotte JB; Staderini E; Aubriot AS; Jossen E; Dugernier J; Liistro G; Reychler G
    J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):33-41. PubMed ID: 28683216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled versus nebulised tobramycin: a real world comparison in adult cystic fibrosis (CF).
    Harrison MJ; McCarthy M; Fleming C; Hickey C; Shortt C; Eustace JA; Murphy DM; Plant BJ
    J Cyst Fibros; 2014 Dec; 13(6):692-8. PubMed ID: 24815094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M; Hyman-Taylor P; Tan KH; Lewis S; Stableforth D; Knox A; Smyth A
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2293-9. PubMed ID: 16801404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.
    Patatanian L
    Pediatr Infect Dis J; 2006 Mar; 25(3):276-8. PubMed ID: 16511399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):51-2. PubMed ID: 23797798
    [No Abstract]   [Full Text] [Related]  

  • 59. Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis.
    Wang X; Koehne-Voss S; Anumolu SS; Yu J
    J Pharm Sci; 2017 Nov; 106(11):3402-3409. PubMed ID: 28634121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of aerosolized tobramycin in adult patients with cystic fibrosis.
    Touw DJ; Jacobs FA; Brimicombe RW; Heijerman HG; Bakker W; Briemer DD
    Antimicrob Agents Chemother; 1997 Jan; 41(1):184-7. PubMed ID: 8980777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.